PHARMACOKINETICS OF MIDAZOLAM IN TOTAL I.V. ANAESTHESIA
|
|
- Madlyn Parsons
- 6 years ago
- Views:
Transcription
1 Br. J. Anaesth. (1987), 59, PHARMACOKINETICS OF MIDAZOLAM IN TOTAL I.V. ANAESTHESIA P. PERSSON, A. NILSSON, P. HARTVIG AND A. TAMSEN Total i.v. anaesthesia, defined as anaesthesia provided solely by drugs administered i.v. has, until now, played a minor role in the provision of anaesthesia for major surgery. However, an awareness of the problems associated with nitrous oxide (Chanarin, 1980; Brodsky, 1983; Mazze, 1983; Wolf, Capuano and Hartung, 1983) has lead to an increased interest in this technique. Midazolam is a benzodiazepine with a short elimination half-life and a relatively short duration of action (Greenblatt et al., 1981; Smith, Eadie and O'Rourke Brophy, 1981). At physiological ph midazolam is un-ionized and lipophilic. As a result the onset of action after i.v. administration is rapid because of rapid uptake by the brain. An understanding of the kinetics of midazolam under the conditions pertaining during surgery, and a knowledge of the plasma concentration required to produce an hypnotic effect are essential when designing a total i.v. technique. Theoretically, the short elimination half-life of midazolam, and the negligible hypnotic effect of its metabolites (Crevoisier et al., 1983; Ziegler et al., 1983), make the administration of midazolam by i.v. infusion potentially useful. The objectives of the present study were: to construct a dose regimen, based on simulations; to determined the pharmacokinetics of midazolam in total i.v. anaesthesia during major surgery; and to compare the simulated and the observed concentration time profiles. PETER PERSSON, PHARM.D., Department of Biopharmaceutics and Pharmacokinetics, University of Uppsala, Biomedical Center, Box 580, S-1 23 Uppsala, Sweden. ANDERS NLLSSON, M.D., ANDERS TAMSEN, M.D., PHJ>. (Department of Anesthesiology); PER HARTVIG, PHARM.D., PH.D. (and P. PERSSON) (Hospital Pharmacy); University Hospital, Uppsala, Sweden. Accepted for Publication: August 1, Correspondence to P.P. SUMMARY The pharmacokinetics of midazolam during total i.v. anaesthesia were determined in 15 female patients undergoing major surgery. Midazolam was administered together with an analgesic drug and a neuromuscu/ar blocking drug. The dose regimen of midazolam. based on simulations, included two consecutive infusions following a bolus injection at the induction of anaesthesia. Multiple blood samples were drawn and a two-compartment open model was fitted to the measured plasma concentrations. Plasma clearance (483 ml min~ l ), apparent volume of distribution (1.94 litre kg~ l ) and terminal halflife (3.1 h) were in agreement with other reports. Thus, there was no obvious evidence that the surgical procedure or the concomitant use of other drugs, or both, influenced the pharmacokinetics of midazolam. The relatively rapid elimination makes midazolam suitable for use by infusion in a total i.v. technique. PATIENTS, MATERIALS AND METHODS Patients Fifteen female patients scheduled for elective hysterectomy were included in the study. Their ages varied from 36 to 53 yr and their body weights were between 45 and 88 kg (mean (± SD) 66±11 kg) (table I). The study was approved by the Ethics Committee of the Medical Faculty of Uppsala University, and informed consent was obtained from each patient. Premedication and anaesthetic procedure. Pethidine mg and atropine 0.5 mg were given i.m. as premedication. Anaesthesia was induced and maintained with midazolam (and alfentanil) as follows:
2 PHARMACOKINETICS OF MIDAZOLAM 549 TABLE I. Body weight, total duration of infusion, total dose of midazolam and area under the concentration-time curve {A UC) in 15 female surgical patients Patient No Mean ±SD Weight (kg) Duration of infusion (min) Total dose (mg) AUC (mg min" 1 litre" 1 ) Patients 1-10: a bolus injection of midazolam 0.3 mg kg" 1 was followed by an infusion regimen with an initial infusion rate of 0.68 mg kg" 1 h" 1 for 15 min followed by a maintenance infusion of mg kg" 1 h" 1 ; Patients 11-15: a bolus dose of midazolam 0.25 mg kg"" 1 followed by an initial infusion of 0.65 mg kg" 1 h" 1 for 15 min and a maintenance infusion of 0. mg kg" 1 h" 1. The mean (± SD) total duration of infusion was 82 ±14 min, corresponding to a total dose of midazolam of mg (table I). In patients 1-5 analgesia was provided by the administration of alfentanil as a bolus dose (0.05 mg kg" 1 ) followed by an infusion (0.06 mg kg" 1 h" 1 ) and additional increments of alfentanil were given when indicated. Patients 6-15 were given a bolus dose of 0.0 mg kg" 1 followed by a two-stage infusion of alfentanil 0.3 mg kg" 1 h" 1 for 15 min followed by mg kg" 1 h" 1 for as long as the midazolam infusion was maintained. Atracurium 0.5 mg kg" 1 (patients 1-5) or pancuronium 0.1 mgkg" 1 (patients 6-15) was given to provide neuromuscular blockade before intubation of the trachea. The lungs were ventilated with oxygen in air during the surgical procedure. At the end of surgery residual neuromuscular blockade was antagonized with neostigmine 2.5 mg (plus atropine 1.0 mg). Intraoperative and postoperative observations. 1*0 1 central peripheral FIG. 1. A two-compartment open model for midazolam used for the simulations. The rate constants (min" 1 ) were taken from the literature (Lauven et al., 1981). k^ represents the infusion rates. Arterial pressure, heart rate and pupil size were monitored during anaesthesia. Any evidence of lachrymation, sweating, or both was noted. End-tidal carbon dioxide concentration, EMG, EEG and train-of-four response were recorded (Datex ABM-monitor (Nilsson and colleagues, 1986; unpublished observations)). The patient's ability to give their name and date of birth and to solve simple arithmetic problems (addition and subtraction of two-figured numbers) in the postoperative period were recorded. Blood sampling and assay. Blood samples were drawn from a peripheral vein before and 2, 5, 10 and 15 min after induction. Thereafter, samples were collected every 15 min until the end of the infusion. Following the termination of the infusion, samples were drawn at 2, 5, 10, 15, 30 and 60 min and then every 1 h for 6 h. The blood was centrifuged and the plasma frozen at 20 C pending analysis. Plasma concentrations of midazolam were determined by gas chromatography using nickel-63 electron capture detection (Rutherford, 1977). Linear standard curves for the concentration range of midazolam ng ml" 1 were obtained. Design of midazolam infusion regimens The dose of midazolam received by the first 10 patients was derived from published pharmacokinetic data obtained following a single bolus dose (table II). A two-compartment open model was assumed (fig. 1) and a continuous simulation program (DARE-P) (Wait and Clarke, 1974) was used to simulate an infusion regimen. After a bolus dose of 0.3 mg kg" 1 a two-stage infusion regimen was constructed. The rapid loading infusion rate was determined after numerous simulations using the two-compartment model. The maintenance
3 550 BRITISH JOURNAL OF ANAESTHESIA TABLE II. Pharmacokinetic data of midazolam used in the simulation. Pharmacokinetic data determined in six female patients undergoing minor gynaecological surgery (Lawen el ai, 1981) Total plasma clearance (ml min" 1 ) Volume of the central compartment (litre kg" 1 ) Apparent volume of distribution (litre kg' 1 ) Distribution half-life (min) Elimination half-life (h) 900 E CD S 600 E.2 o N CO." Mean Range Time (min) FIG. 2. Simulated concentration-time profile for midazolam after two consecutive infusion rates combined with a bolus injection. The bolus injection was 0.3 mg kg" 1, while the infusion rates were 0.68 mg kg"' h" 1 for 15 min followed by mg kg" 1 h" 1 over the next 285 min. infusion was calculated from the equation (Rowland and Tozer, 1980): k o = Cl-C» (1) where k 0 was the maintenance infusion rate, Cl was the total plasma clearance and C 55 the desired steady-state concentration. In patients 1-10 this infusion regimen was theoretically expected to result in a steady-state concentration of 300 ng ml" 1 from 45 min onwards (fig. 2), a value which has been found to provide adequate sedation during surgery (Nilsson, Tamsen and Persson, 1986). The infusion regimen for patients was based on the results obtained in patients Theoretically, the aim of this regimen was to give a steady-state concentration of midazolam 250 ng ml" 1 from 45 min onwards. Data analysis The differential equations (Appendix) were fitted to the individual plasma concentration-time data by the non-linear least square regression program DARE-MINUIT (University of Uppsala, Uppsala, Sweden). The data points were given different weights (equal, \/y) to obtain the best fit. The pharmacokinetics of midazolam were calculated using the equations given in the Appendix. Statistical analysis Mean values and standard deviations were calculated using standard equations. All data are presented as mean±sd. Comparison between groups was made with Student's t test. A P-value < 0.05 was considered significant. Linear regression was used to evaluate the relationship between the pharmacokinetics and body weight: correlation coefficients were calculated according to Pearson (Colton, 1974). RESULTS Pharmacokinetics The relationships between mean plasma midazolam concentrations and time, for the two patient groups (1-10 and 11-15) are shown in figure 3. The mean initial concentrations, 2 min after the bolus dose, were 1254 ± 626 ng ml" 1 in patients 1-10 and 919±272ngml~ 1 in patients These values were not significantly different (P > 0.05). The mean concentrations at the end of the infusion were 317 ±74 ng ml" 1 (range ng ml" 1 ) in the first group and 3±48ngml" 1 (range ng ml" 1 ) in the second group of patients (P > 0.05). The simulated concentration, 2 min after the bolus dose, was 52% lower than the mean observed concentration. At the end of the infusion this difference was 6 % in patients 1-10, compared with 47% in patients The simulated concentrations, 30 min after the end of the infusion, were 14% higher in patients 1-10 and 22% lower in patients The best individual fit to the pharmacokinetic data following i.v. infusion was obtained by a
4 PHARMACOKINETICS OF MIDAZOLAM ' r M Time (mm) Time (mini FIG. 3. Observed midazolam plasma concentrations for patients 1-10 (top) and for patients (bottom). Mean values±sem. I and II represent the duration of the first and the second infusion, respectively. two-compartment open model (fig. 1). The resulting fit to the data for one patient is shown in figure 4. The mean values of the calculated rate constants are shown in table III. The total plasma clearance (C/) of midazolam was 483 ±109 ml min" 1, range ml min" 1. After correction for body weight the variations in clearance ranged between 5.55 and ml min" 1 kg" 1. The mean clearance in patients 1-10 was 512 ml min" 1 compared with 426 ml min" 1 in patients The apparent volume of distribution (FDP) for midazolam also showed a two-fold variation ( litre kg" 1 ) with a mean of 1.94±0.55 litre kg" 1. This resulted in a mean terminal elimination half-life (TjP) of 3.1 h (range h) while the mean half-life for the distribution phase (7*j a ) was 18 min. The volume TABLE III. Mean values of the calculated rate constant! of midazolam in IS surgical patients Mean ±SD (min ') (min- 1 ) (min" 1 )
5 552 BRITISH JOURNAL OF ANAESTHESIA 1000 ^ 300 I I E Time (mm) 480 FIG. 4. Midazolam plasma concentrations for patient No. 7. The straight line represents the fit; the broken line represents the simulated concentrations. I = Initial infusion; II = maintenance infusion. of the central compartment was litre kg" 1 ±0.1. The individual pharmacokinetic parameters are presented in table IV. There was a good correlation between body weight and the total apparent volume of distribution (r = 0.72; P < 0.01) with a tendency towards a proportionate increase in volume of distribution even after correction for body weight (r = 0.428; P > 0.05) (fig. 5). Furthermore, there was a weak correlation between the elimination half-life and increasing body weight (r = 0.567; P < 0.05). On the other hand, total clearance (Cl) did not change significantly with increasing body weight (r = ; P > 0.05). The mean blood loss during the investigation was around ml (includes surgery and blood sampling). Correlation between performance and plasma concentration The mean plasma concentration of midazolam at the time of extubation was 166 ±38 ng ml" 1. TABLE IV. Individual pharmacokinetic parameters of midazolam in 15 surgical patients: total plasma clearance (Cl), volume of the central compartment (V,), apparent volume of distribution (Vr/), distribution half-life (T ") and the elimination half-life ^ Pauent No. Cl (ml min" 1 ) (litre kg (litre kg~ J f (min) 'IT (h) Mean ±SD :
6 PHARMACOKINETICS OF MIDAZOLAM o E ~ 160 a o N CD S 120 'S Body weight (kg) r FIG. 5. Correlation of total body weight to midazolam volume of distribution (Kr>P) (expressed both with and without correction for total body weight). Solid lines were determined by linear regression analysis. Mean time from extubation until the patient was able to give her name and date of birth was 76 ±62 min; mean plasma concentration of midazolam at this time was 104 ±38 ngml" 1. The ability to solve simple arithmetic problems was established at 89 ±63 min after extubation; the corresponding plasma concentration of midazolam was 96 ±42 ngml" 1. DISCUSSION Drugs administered i.v. in anaesthetic practice are usually characterized by a rapid onset, and a short duration, of action. For most agents, the short duration of action results from a rapid decrease in plasma concentration as a result of extensive redistribution from brain to poorly-perfused tissues. However, when an infusion is administered i.v. at a constant rate, the total body 90 clearance of the drug determines the steady-state plasma concentration, and the terminal elimination half-life has an important influence on the duration of action after the discontinuation of the infusion. When considering the pharmacodynamic and pharmacokinetic properties of drugs in total i.v. anaesthesia, account has to be taken of the various factors which can influence the action of the drugs, such as the hepatic blood flow, protein binding and the drug metabolizing capacity of the patient as well as the concomitant use of other drugs. Knowledge of the plasma concentration required for hypnotic or analgesic effects as well as reliable pharmacokinetic data are also essential. Pharmacokinetics of midazolam A three-compartment model for midazolam has been proposed (Smith, Eadie and O'Rourke Brophy, 1981; Avram, Fragen and Caldwell, 1983). However, a biexponential elimination gave the best fit to the individual data in this study, and the midazolam kinetics obtained were similar to those reported by others. The mean total plasma clearance of 483 ml min" 1 was similar to those found in healthy volunteers (Greenblatt et al., 1984; Smith, Eadie and O'Rourke Brophy, 1981) and in surgical patients (Lauven et al., 1981; Avram, Fragen and Caldwell, 1983; Harper et al., 1985). Changes in hepatic blood flow during surgery may influence total body clearance. However, the clearance values found in the present study did not differ from those reported from studies in healthy volunteers indicating a negligible influence of surgery. The apparent volume of distribution (FDP) of midazolam obtained in the present study (1.94 litre kg" 1 ) was comparable to those in previous studies (Lauven et al., 1981; Smith Eadie and O'Rourke Brophy, 1981; Harper et al., 1985). The tendency towards an increasing volume of distribution with increasing body weight (fig. 5) indicates that the bolus injection and loading infusion should be relatively higher in obese patients. On the other hand, there was no indication for a different maintenance infusion in these patients, since the plasma clearance did not depend on body weight. The influence of body weight on midazolam disposition is consistent with the findings of others for midazolam (Greenblatt et al., 1984), and for other lipophilic benzodiazepines such as diazepam (Abernethy and Greenblatt, 1982).
7 554 The infusion regimen This study was based on the assumption that the hypnotic effect of midazolam is correlated with its plasma concentration (Allonen, Ziegler and Klotz, 1981; Aaltonen et al., 1985). Compared with midazolam, the main metabolite a-hydroxy midazolam has less hypnotic activity and a shorter elimination half-life (Crevoisier et al., 1983; Ziegler et al., 1983), indicating that a continuously maintained plasma concentration of midazolam should give a stable therapeutic effect without cumulation. In a previous study, a plasma concentration of midazolam of around ng ml" 1 was found to produce satisfactory anaesthesia during major surgery when used in combination with fentanyl (Nilsson, Tamsen and Persson, 1986). The time taken to attain a steady-state plasma concentration is dependent upon the half-life of the drug. Approximately 90 % of the steady-state concentration will be attained after three halflives, that is about 9 h for midazolam. However, in a two-compartment system (as for midazolam) the time to reach the steady-state plasma concentration depends on the fraction of the total area (AUC) associated with the terminal phase. If this fraction is small, then the time to reach a plasma steady-state will be governed mainly by the distribution half-life (7^ ). However, for midazolam the terminal half-life will primarily determine the time to reach a steady-state plasma concentration, since the terminal phase represents the major part of the total area. To achieve a steady-state concentration more rapidly, a bolus dose was combined with a two-stage infusion regimen. There are several possible approaches to designing an infusion regimen (Wagner, 1974; Schwilden et al., 1983). The advantage of the present method is that the high initial concentration produced a relatively rapid onset of action. It is an advantage to have a relatively high concentration of the anaesthetic drug at the moment of intubation and at the beginning of surgery, and the high therapeutic index (Pieri et al., 1981) of midazolam did not contraindicate this method. Prolonged infusion will not, with the present infusion strategy, result in an increasing plasma concentration of midazolam. This is important, since a high concentration at the end of surgery could lead to marked postoperative sedation. BRITISH JOURNAL OF ANAESTHESIA The dose regimen calculated from simulations in a two-compartment model indicated a constant concentration of midazolam from 45 min onwards (fig. 2). In some patients, however, a steady-state concentration was not achieved during the infusion. The main reason for the discrepancy between simulated and observed data in these patients is probably the assumption of instantaneous equilibrium within each compartment in the simulation model. In reality, the distribution process within each compartment might have been slower. This is probably the explanation of the fact that the observed concentration, 2 min after the bolus dose, was significantly higher than the simulated concentration. Moreover, the relatively short period of infusion was probably insufficient to establish steady-state conditions. However, there is a tendency to a plateau phase (fig. 3) with reasonably good correlations with predicted values, although there were rather large interindividual differences. Midazolam is almost completely metabolized in the liver indicating an intermediate value of hepatic extraction ratio of midazolam. Thus, the clearance of midazolam depends on the metabolic capacity of the liver, the fraction of unbound midazolam and the hepatic blood flow (Rowland, Benet and Graham, 1973; Wilkinson and Shand, 19). Interindividual differences in these indices may influence the concentration at, and the time to achieve, steady-state. In fact, the interindividual variability in the pharmacokinetics was greater in the present study than in the study by Lauven and colleagues (1981) (table II; table IV). Patients 1-10 showed a slightly higher plasma clearance than had initially been assumed. Patients had their infusion regimen modified based on the results from these first 10 patients. The aim of the modified regimen was to decrease the steady-state value and, thereby, decrease postoperative sedation. However, the steady-state value achieved in patients did not differ from that in the first 10 patients, most probably as a result of the fact that patients had a lower mean plasma clearance than patients On the other hand, the peak values were reduced. Concentration and effect of midazolam after infusion The initial decrease in the plasma concentration of midazolam after the termination of the infusion was rapid, from about 350 ng ml" 1 to 150 ng ml" 1 in 1 h. Clinically, these values correspond to an
8 PHARMACOKINETICS OF MIDAZOLAM 555 anaesthetized patient and to a patient responding to verbal stimuli in the postoperative period, respectively. This rapid decline is partly the result of metabolism and partly the result of the continuous re-distribution of midazolam from the central to the peripheral compartment. Following this rapid phase, however, the decline in plasma concentration is slower, the patients often drifting back into sleep when undisturbed. This phase lasts for several hours, indicating that midazolam is being released slowly from the peripheral compartment. The data demonstrated a relatively good correlation between the plasma concentrations of midazolam and postoperative sedation, despite the variations in the alfentanil plasma concentrations (Persson and colleagues, 1986; unpublished observations). Concentrations of midazolam in excess of 50- ng ml" 1 signify postoperative drowsiness. When simulated and observed plasma concentrations are compared, a tendency is seen for the simulated concentration to be lower during the infusion and higher after the termination of the infusion. This could partly be explained, as mentioned above, by the fact that a steady-state condition was not achieved during the investigation. After the termination of the infusion this would result in a greater distribution from the central to the peripheral compartment than that predicted by the simulation. After the infusion, distribution will have less influence than elimination on the plasma concentration decay with time. Theoretically, this implies that the duration of the hypnotic effect and hence, postoperative sedation, might be more pronounced after the infusion, than following a single i.v. bolus. CONCLUSION This investigation showed that, during surgery and in combination with the opioid drug alfentanil, midazolam showed a pharmacokinetic behaviour not unlike that previously reported from studies in healthy volunteers. We believe that the predictable, and relatively rapid, elimination of midazolam (and the low hypnotic activity of its metabolites) make midazolam a suitable hypnotic for use in a total i.v. technique. APPENDIX Midazolam kinetics after the infusion regimen are described by differential equations according to a two-compartment model (fig. 1): Change of the amount of drug (/I,) with time in the central compartment: da,/dt = J? ln,-*,o At-k,, A, +* A, where R tal = rate of infusion (mg min" 1 )- Change of the amount of drug (A,) with time in the peripheral compartment: The resulting concentration-time profile in the central compartment (C,) was obtained by the following relationship: where V l = volume of central compartment (1). The disposition rate constants (or and ft) were estimated from the fractional rate constants: The total plasma clearance (CO and the apparent volume of distribution (VD$) were calculated from: Total dose AUC The area under the concentration-time curve (AUC) was calculated by the trapezoidal rule. The residual area beyond the last sampling point to infinity was determined from the calculated concentration at the final sampling time divided by the terminal slope (/J). ACKNOWLEDGEMENT The authors thank Ms Veiny Eriksson for technical assistance. The study was financially supported by a grant from Roche-Produkter AB, Sweden. REFERENCES Aaltonen, L., Himberg, J.-J., Kanto, J., and Vouri, A. (1985). The usefulness of radiorecoptor assay and gas liquid chromatography in pharmacokinetic studies on midazolam. Int. J. Clin. Pharm. Ther. Toxicol., 23, 247. Abemethy, D. R., and Greenblatt, D. J. (1982). Pharmacokinetics of drugs in obesity. Clin. Pharmacokinet., 7, 108. Allonen, H., Ziegler, G., and Klotz, U. (1981). Midazolam kinetics. Clin. Pharmacol. Ther., 30, 653. Avram, M. J., Fragen, R. J., and Caldwell, N. J. (1983). Midazolam kinetics in women of two age groups. Clin. Pharmacol. Ther., 34, 505. Brodsky, J. B. (1983). The toxicity of nitrous oxide; in Clinics in Anaesthesiology, 1, p Eastbourne: Saunders. Chanarin, I. (1980). Cobalamine and nitrous oxide: a review. J. Clin. Pathol., 33, 909. Colton, T. (1974). Statistics in Medicine, p Boston: Little, Brown and Company. Crevoisier, C, Ziegler, W. H., Eckert, M., and Heizmann, P. (1983). Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. Br.J. Clin. Pharmacol., 16, 5IS.
9 556 BRITISH JOURNAL OF ANAESTHESIA Greenblatt, D. J., Abernethy, D. R., Locniskar, A., Harmatz, J. S., Limjuco, R. A., and Shader, R. I. (1984). Effect of age, gender and obesity on midazolam kinetics. Anesthesiology, 61, 27. Locniskar, A., Ochs, H. R., and Lauven, P. M. (1981). Automated gas chromatography for studies of midazolam pharmacokinetics. Anesthesiology, 55, 176. Harper, K. W., Collier, P. S., Dundee, J. W., Elliott, P., Halliday, N. J., and Lowry, K. G. (1985). Age and nature of operation influence the pharmacokinetics of midazolam. Br. J. Anaesth., 57, 866. Lauven, P. M., Stoeckel, H., Ochs, H., and Greenblatt, D. J. (1981). Pharmakokinetische untersuchungen mit dem neuen wasserloslichen benzodiazepin midazolam. Anaesthetist, 30, 280. Mazze, R. 1.(1983). Waste anaesthetic gases: a health hazard?; in Climes in Anaesthesiology, 1, p Eastbourne: Saunders. Nilsson, A., Tamsen, A., and Persson, P. (1986). Midazolamfentanyl anaesthesia for major surgery. Plasma levels of midazolam during prolonged total intravenous anaesthesia. Acta Anaesthesiol. Scand., 30, 66. Pieri, L., Schaffner, R., Scherschlicht, R., Pole, P., Sepinwall, J., Davidson, A., Mohler, H., Cumin, R., Da Prada, M., Burchard, W. P., KeUcr, H. H., Muller, R. K. M., Pieri, M., Cook, L., and Haefely, W. (1981). Pharmacology of midazolam. Arzneim.-Forsch., 31, Rowland, M., Benet, L. Z., and Graham, G. C. (1973). Clearance concepts in pharmacokinetics. J. Pharmacokinet. Biopharm., 1, 123. Rowland, M., and Tozer, T. N. (1980). Clinical Pharmacokinetics : Concepts and Applications, p. 98. Philadelphia: Lea Febiger. Rutherford, D. M. (1977). Rapid micro-method for the measurement of diazepam and desmethyldiazepam in blood plasma by gas-liquid chromatography. J. Chromatogr., 7, 439. Schwilden, H., Schuttler, J., Stoeckel, H., and Lauven, P. M. (1983). Pharmacological Basis of Anesthesiology: Clinical Pharmacology of New Analgesics and Anesthetics, p New York: Raven Press. Smith, M. T., Eadie, M. J., and O'Rourke Brophy, T. (1981). The pharmacokinetics of midazolam in man. Eur. J. Clin. Pharmacol., 19,271. Wagner, J. G. (1974). A safe method for rapidly achieving plasma concentration plateaus. Clin. Pharmacol. Ther., 16, 691. Wait, J. V., and Clarke, F. (1974). DARE-P, a portable digital simulation system. University of Arizona, Tuscon, U.S.A. Wilkinson, G. R., and Shand, D. G. (19). A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther., 18, 377. Wolf, G. L., Capuano, C, and Hartung, J. (1983). Nitrous oxide increases intraocular pressure after intravitreal sulfor hexaflouride injection. Anesthesiology, 59, 547. Ziegler, W. H., Schalch, E., Leishman, B., and Eckert, M. (1983). Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites. Br. J. Clin. Pharmacol., 16, 63S.
Pharmacokinetics of propofol when given by intravenous
Br. J. clin. Pharmac. (199), 3, 144-148 Pharmacokinetics of propofol when given by intravenous infusion DENIS J. MORGAN', GWEN A. CAMPBELL2,* & DAVID P. CRANKSHAW2 'Victorian College of Pharmacy, 381 Royal
More informationPHARMACOKINETICS OF FENTANYL DURING CONSTANT RATE I.V. INFUSION FOR THE RELIEF OF PAIN AFTER SURGERY
Br. J. Anaesth. (1986), 58, 950-956 PHARMACOKINETICS OF FENTANYL DURING CONSTANT RATE I.V. INFUSION FOR THE RELIEF OF PAIN AFTER SURGERY D. J. R. DUTHIE, A. D. McLAREN AND W. S. NIMMO Acute pain after
More informationFENTANYL BY CONSTANT RATE I.V. INFUSION FOR POSTOPERATIVE ANALGESIA
Br. J. Anaesth. (1985), 5, 250-254 FENTANYL BY CONSTANT RATE I.V. INFUSION FOR POSTOPERATIVE ANALGESIA W. S. NIMMO AND J. G. TODD is a synthetic opioid analgesic 50 times more potent than morphine, with
More informationPharmacokinetics of drug infusions
SA Hill MA PhD FRCA Key points The i.v. route provides the most predictable plasma concentrations. Pharmacodynamic effects of a drug are related to plasma concentration. Both plasma and effect compartments
More informationBenzodiazepines and postoperative cognitive dysfunction in the elderly
British Journal of Anaesthesia 83 (4): 585 9 (1999) Benzodiazepines and postoperative cognitive dysfunction in the elderly L. S. Rasmussen 1 *, A. Steentoft 2, H. Rasmussen 3, P. A. Kristensen 4, J. T.
More informationBasic pharmacokinetics. Frédérique Servin APHP hôpital Bichat Paris, FRANCE
Basic pharmacokinetics Frédérique Servin APHP hôpital Bichat Paris, FRANCE DOSE CONCENTRATION EFFECT Pharmacokinetics What the body does to the drug Pharmacodynamics What the drug does to the body Transfer
More informationPLASMA FENTANYL CONCENTRATIONS DURING TRANSDERMAL DELIVERY OF FENTANYL TO SURGICAL PATIENTS
Br. J. Anaesth. (988), 6, 64-68 PLASMA FENTANYL CONCENTRATIONS DURING TRANSDERMAL DELIVERY OF FENTANYL TO SURGICAL PATIENTS D. J. R. DUTHIE, D. J. ROWBOTHAM, R. WYLD, P. D. HENDERSON AND W. S. NIMMO Pain
More informationSEDATION OF CHILDREN REQUIRING ARTIFICIAL VENTILATION USING AN INFUSION OF MIDAZOLAM
Br.J. Anaesth. (986), 8, 0-08 SEDATION OF CHILDREN REQUIRING ARTIFICIAL VENTILATION USING AN INFUSION OF MIDAZOLAM P. D. BOOKER, A. BEECHEY AND A. R. LLOYD-THOMAS Long-term intubation of the trachea and
More informationBasic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy
Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy I. General principles Applied pharmacokinetics - the process of using drug concentrations, pharmaco-kinetic
More informationEfficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting
European Review for Medical and Pharmacological Sciences 2001; 5: 59-63 Efficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane
More informationHST-151 Clinical Pharmacology in the Operating Room
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructors: Dr. Carl Rosow, Dr. David Standaert and Prof. Gary Strichartz 1 HST-151 Clinical Pharmacology in
More informationPharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic
Gut 1986, 27, 190-195 Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis A J MACGILCHRIST, G G BIRNIE, A COOK, G SCOBIE, T MURRAY, G WATKINSON, AND
More informationPHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 4120 Second Exam Key Fall 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /10 ponts 2. /20 points 3. /10 points 4. /10 points
More informationNITROUS OXIDE ELIMINATION AND DIFFUSION HYPOXIA DURING NORMO- AND HYPOVENTILATION
British Journal of Anaesthesia 1993; 71: 189-193 NITROUS OXIDE ELIMINATION AND DIFFUSION HYPOXIA DURING NORMO- AND HYPOVENTILATION S. EINARSSON, O. STENQVIST, A. BENGTSSON, E. HOULTZ AND J. P. BENGTSON
More informationBASIC PHARMACOKINETICS
BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter
More informationBasic Concepts of TDM
TDM Lecture 1 5 th stage What is TDM? Basic Concepts of TDM Therapeutic drug monitoring (TDM) is a branch of clinical pharmacology that specializes in the measurement of medication concentrations in blood.
More informationTime to Lowest BIS after an Intravenous Bolus and an Adaptation of the Time-topeak-effect
Adjustment of k e0 to Reflect True Time Course of Drug Effect by Using Observed Time to Lowest BIS after an Intravenous Bolus and an Adaptation of the Time-topeak-effect Algorithm Reported by Shafer and
More informationCLOSED-LOOP FEEDBACK CONTROL OF PROPOFOL ANAESTHESIA BY QUANTITATIVE EEG ANALYSIS IN HUMANS
Br. J. Anaesth. (1989), 62, 290-296 CLOSED-LOOP FEEDBACK CONTROL OF PROPOFOL ANAESTHESIA BY QUANTITATIVE EEG ANALYSIS IN HUMANS H. SCHWILDEN, H. STOECKEL AND J. SCHUTTLER The electroencephalogram (EEG)
More informationPHA5128 Dose Optimization II Case Study I Spring 2013
Silsamicin is an investigational compound being evaluated for its antimicrobial effect. The route of administration for this drug is via intravenous bolus. Approximately 99.9% of this drug is eliminated
More informationChapter 25. General Anesthetics
Chapter 25 1. Introduction General anesthetics: 1. Analgesia 2. Amnesia 3. Loss of consciousness 4. Inhibition of sensory and autonomic reflexes 5. Skeletal muscle relaxation An ideal anesthetic: 1. A
More informationLong term high dose morphine, ketamine and midazolam infusion in a child with burns
Br. J. clin. Pharmac. (1990), 30, 901-905 Long term high dose morphine, ketamine and midazolam infusion in a child with burns I. CEDERHOLM', M. BENGTSSON', S. BJORKMAN2, I. CHOONARA' & A. RANE3 'Department
More informationPOST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS
Br. J. Anaesth. (9), 60, 3-35 POST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS S. A. RIDLEY AND D. J. HATCH Atracurium degrades rapidly and, because
More informationPropofol administered by a manual infusion regimen
British Journal of Anaesthesia 995; 74: 362-367 CLINICAL INVESTIGATIONS Propofol administered by a manual infusion regimen J. W. SEAR AND J. B. GLEN Summary We have evaluated the clinical utility and blood
More informationSign up to receive ATOTW weekly Regarding the use of propofol in total intravenous anaesthesia:
TARGET CONTROLLED INFUSIONS IN ANAESTHETIC PRACTICE ANAESTHESIA TUTORIAL OF THE WEEK 75 26th NOVEMBER 2007 Dr Subash Sivasubramaniam University Hospitals of North Staffordshire subashken@yahoo.com SELF
More informationThe effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics
Br. J. clin. Pharmac. (1984), 18, 393-400 The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics T. K. DANESHMEND* & C. J. C. ROBERTS University Department of Medicine, Bristol
More informationINTERACTION OF MIDAZOLAM WITH TWO NON-DEPOLARIZING NEUROMUSCULAR BLOCKING DRUGS IN THE RAT IN VIVO SCIATIC NERVE-TIBIALIS ANTERIOR MUSCLE PREPARATION
Br.J. Anaesth. (1985), 57, 1089-1094 INTERACTION OF MIDAZOLAM WITH TWO NON-DEPOLARIZING NEUROMUSCULAR BLOCKING DRUGS IN THE RAT IN VIVO SCIATIC NERVE-TIBIALIS ANTERIOR MUSCLE PREPARATION J. J. DRIESSEN,
More informationPREMEDICATION WITH SLOW RELEASE MORPHINE (MST) AND ADJUVANTS
Br. J. Anaesth. (1988), 60, 825-830 PREMEDICATION WITH SLOW RELEASE MORPHINE (MST) AND ADJUVANTS K. H. SIMPSON, M. J. DEARDEN, F. R. ELLIS AND T. M. JACK Opioids are used widely for premedication, as they
More informationPHA Final Exam Fall 2006
PHA 5127 Final Exam Fall 2006 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More informationBasic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations
Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Rosenbaum, Sara E. ISBN-13: 9780470569061 Table of Contents 1 Introduction to Pharmacokinetics and Pharmacodynamics.
More informationNontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment
Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Please consider the following questions. If you do not feel confident about the material being covered, then it is recommended
More informationPAIN Pharmacokinetics of controlled release morphine (MST) in patients with liver carcinoma
British Journal of Anaesthesia 94 (1): 95 9 (2005) doi:10.1093/bja/aei007 Advance Access publication October 29, 2004 PAIN Pharmacokinetics of controlled release morphine (MST) in patients with liver carcinoma
More informationBioavailability and Related Pharmacokinetics in Man of Orally Administered L-5-Hydroxytryptophan in Steady State
Acra pharmacol. et roxicol. 1980, 46, 257-262. From the University Department of Neurology, the Research Laboratory for etabolic Disorders of the University Department of Clinical Chemistry, Aarhus Kornrnunehospital,
More informationPharmacokinetics of ibuprofen in man. I. Free and total
Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships Ibuprofen kinetics were studied in 15 subjects after four oral doses. Plasma levels of both total and free ibuprofen were
More informationOsnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne,
Osnove farmakokinetike Aleš Mrhar Prirejeno po A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne, College of Pharmacy, University of Oklahoma Pharmacokinetics/Pharmacodynamics Pharmacodynamics
More informationMIDAZOLAM AND OXAZEPAM IN THE TREATMENT OF INSOMNIA IN HOSPITALIZED PATIENTS
Br. J. clin. Pharmac. (1983), 16, 145S-149S MIDAZOLAM AND OXAZEPAM IN THE TREATMENT OF INSOMNIA IN HOSPITALIZED PATIENTS 'Clinique des Maladies Infectieuses, H6pital Houphouet Boigny, Marseilles, France
More informationTDM. Generally, hepatic clearance is determined by three main factors: These three factors can be employed in the following equation:
Lecture 9: Very important supplements TDM Effect of hepatic disease on drugs monitoring: Generally, hepatic clearance is determined by three main factors: - Liver blood flow (LBF). - Intrinsic capacity
More informationControlled Trial of Wound Infiltration with Bupivacaine for Post Operative Pain Relief after Caesarean Section
Bahrain Medical Bulletin, Vol.23, No.2, June 2001 Controlled Trial of Wound Infiltration with Bupivacaine for Post Operative Pain Relief after Caesarean Section Omar Momani, MD, MBBS, JBA* Objective: The
More informationAnalgesia is a labeled indication for all of the approved drugs I will be discussing.
Comparative Opioid Pharmacology Disclosure Analgesia is a labeled indication for all of the approved drugs I will be discussing. I ve consulted with Glaxo (remifentanil), Abbott (remifentanil), Janssen
More information8 Respiratory depression by tramadol in the cat: involvement of opioid receptors?
8 Respiratory depression by tramadol in the cat: involvement of opioid receptors? A MAJOR ADVERSE effect of opioid analgesics is respiratory depression which is probably mediated by an effect on µ-opioid
More informationLorazepam and oxazepam kinetics in women on low-dose oral contraceptives
Loraepam and oxaepam kinetics in women on low-dose oral contraceptives Women on low-dose estrogen oral contraceptives (OC) and drug-free control women matched for age, weight, and cigarette smoking habits,
More informationTDM. Measurement techniques used to determine cyclosporine level include:
TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.
More informationSetting The setting was a hospital (tertiary care). The economic study was carried out in Ankara, Turkey.
Inhalation versus total intravenous anesthesia for lumbar disc herniation: comparison of hemodynamic effects, recovery characteristics, and cost Ozkose Z, Ercan B, Unal Y, Yardim S, Kaymaz M, Dogulu F,
More informationCOMPARISON OF INFUSIONS OF ALFENTANIL OR PETHIDINE FOR SEDATION OF VENTILATED PATIENTS ON THE ITU
Br.J. Anaesth. (1986), 58, 1091-1099 COPARISON OF INFUSIONS OF ALFENTANIL OR PETHIDINE FOR SEDATION OF VENTILATED PATIENTS ON THE ITU P.. YATE, D. THOAS, S.. SHORT, P. S. SEBEL AND J. ORTON The ideal agent
More informationPHARMACOKINETICS OF DRUG ABSORPTION
Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Applied Biopharmaceutics & Pharmacokinetics > Chapter 7. Pharmacokinetics of Oral Absorption >
More informationAUSTRALIAN PRODUCT INFORMATION REMIFENTANIL APOTEX (REMIFENTANIL HYDROCHLORIDE) POWDER FOR INJECTION
AUSTRALIAN PRODUCT INFORMATION REMIFENTANIL APOTEX (REMIFENTANIL HYDROCHLORIDE) POWDER FOR INJECTION 1 NAME OF THE MEDICINE Remifentanil (as hydrochloride) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationPharmacokinetics Overview
Pharmacokinetics Overview Disclaimer: This handout and the associated lectures are intended as a very superficial overview of pharmacokinetics. Summary of Important Terms and Concepts - Absorption, peak
More informationPHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Second Exam Fall 2011 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /200 pts 1 Question Set I (True or
More informationRichard A. Beers, M.D. Professor, Anesthesiology SUNY Upstate Medical Univ VA Medical Center Syracuse, NY
Richard A. Beers, M.D. Professor, Anesthesiology SUNY Upstate Medical Univ VA Medical Center Syracuse, NY beersr@verizon.net 2 Improvements in safety and advances in care are re-invested in older, sicker
More informationOH3 PHARMACOKINETICS AND BIOAVAILABILITY OF MIDAZOLAM IN MAN
Br. J. clin. Pharmac. (1983), 16, 43S-49S PHARMACOKINETICS AND BIOAVAILABILITY O MIDAZOLAM IN MAN P. HEIZMANN, M. ECKERT & W.H. ZIEGLER*. Hoffmann-La Roche & Co. Ltd, CH-4002 Basle and *Division of Clinical
More informationKetoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults?
British Journal of Anaesthesia 82 (1): 56 60 (1999) Ketoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults? P. Tarkkila* and L. Saarnivaara Department of Anaesthesia, Otolaryngological
More informationSEDATION FOR SMALL PROCEDURES
SEDATION FOR SMALL PROCEDURES Sinno Simons Erasmus MC Sophia Children s Hospital Rotterdam, the Netherlands s.simons@erasmusmc.nl SEDATION in newborns How and when How to evaluate How to dose Why to use
More informationR. A. COOPER, V. R. MADDINENI, R. K. MIRAKHUR, J. M. K. H. WIERDA, M. BRADY AND K. T. J. FITZPATRICK. British Journal of Anaesthesia 1993; 71:
British Journal of Anaesthesia 13; 71: 222-226 TIME COURSE OF NEUROMUSCULAR EFFECTS AND PHARMACOKINETICS OF ROCURONIUM BROMIDE (ORG 426) DURING ISOFLURANE ANAESTHESIA IN PATIENTS WITH AND WITHOUT RENAL
More informationOptimization Methods to Minimize Emergence Time While Maintaining Adequate Post-Operative Analgesia
Optimization Methods to Minimize Emergence Time While Maintaining Adequate ost-operative Analgesia arl Tams BS, Noah Syroid MS, Ken B. Johnson MD, Talmage D. Egan MD, Dwayne Westenskow hd ABSTAT A rapid
More informationPOTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE
Br.J. Anaesth. (987), 9, 0-06 POTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE S. J. KEENS, J. M. HUNTER, S. L. SNOWDON AND J. E. UTTING Volatile
More informationCONCENTRATIONS OF DIETHYL ETHER IN THE BLOOD OF INTUBATED AND NON-INTUBATED PATIENTS
Brit. J. Anaesth. (1954), 26, 111. CONCENTRATIONS OF DIETHYL ETHER IN THE BLOOD OF INTUBATED AND NON-INTUBATED PATIENTS BY A. MACKENZIE, E. A. PASK AND J. G. ROBSON Medical School, King's College, and
More informationThe pharmacokinetics and dose proportionality of cilazapril
Br. J. clin. Pharmac. (1989), 27, 199S-204S The pharmacokinetics and dose proportionality of cilazapril J. MASSARELLA, T. DEFEO, A. LIN, R. LIMJUCO & A. BROWN Departments of Drug Metabolism and Clinical
More informationDisposition of metronidazole and its effects on sulphasalazine
Br. J. clin. Pharmac. (1986), 21, 431-435 Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease J. L. SHAFFER*,' A. KERSHAW2 & J. B. HOUSTON2
More informationSingle dose pharmacokinetic study of clobazam in normal
Br. J. clin. Pharmac. (1984), 18, 873-877 Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients S. JAWAD & A.. RICHS Department of Pharmacology and Therapeutics, Welsh
More informationN-monodesmethyldiltiazem is the predominant metabolite of
Br. J. clin. Pharmac. (1987), 24, 185-189 N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives S. C. MONTAMAT & D. R. ABERNETHY Section on
More informationOral Midazolam for Premedication in Children Undergoing Various Elective Surgical procedures
Oral Midazolam for Premedication in Children Undergoing Various Elective Surgical procedures E-mail gauripanjabi@yahoo.co.in 1 st Author:. Dr Panjabi Gauri M., M.D., D.A., Senior Assistant professor. 2
More informationPHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Final Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More informationThe correlation of bispectral index with endtidal sevoflurane concentration and haemodynamic parameters in preschoolers
Paediatric Anaesthesia 2002 12: 519 525 The correlation of bispectral index with endtidal sevoflurane concentration and haemodynamic parameters in preschoolers MARY ELLEN MCCANN MD, JULIANNE BACSIK MD,
More informationAwake regional versus general anesthesia in preterms and ex-preterm infants for herniotomy
Awake regional versus general anesthesia in preterms and ex-preterm infants for herniotomy Department of Anaesthesia University Children s Hospital Zurich Switzerland Epidemiology Herniotomy needed in
More informationSedation For Cardiac Procedures A Review of
Sedation For Cardiac Procedures A Review of Sedative Agents Dr Simon Chan Consultant Anaesthesiologist Department of Anaesthesia and Intensive Care Prince of Wales Hospital Hong Kong 21 February 2009 Aims
More informationPRODUCTION OF LAUDANOSINE FOLLOWING INFUSION OF ATRACURIUM IN MAN AND ITS EFFECTS ON AWAKENING
Br. J. Anaesth. (1989), 63, 76-80 PRODUCTION OF LAUDANOSINE FOLLOWING INFUSION OF ATRACURIUM IN MAN AND ITS EFFECTS ON AWAKENING G. H. BEEMER, A. R. BJORKSTEN, P. J. DAWSON AND D. P. CRANKSHAW The continuous
More informationSedation in Children
CHILDREN S SERVICES Sedation in Children See text for full explanation and drug doses Patient for Sedation Appropriate staffing Resuscitation equipment available Monitoring equipment Patient suitability
More informationPharmacokinetic concepts for TCI anaesthesia
Pharmacokinetic concepts for TCI anaesthesia E. Gepts Department of Anaesthesiology, UVC Sint Pieter, 322 Hoogstraat, 1000 Brussels, Belgium Summary The development of new short-acting anaesthetic drugs,
More informationDelayed Drug Effects. Distribution to Effect Site. Physiological Intermediate
1 Pharmacodynamics Delayed Drug Effects In reality all drug effects are delayed in relation to plasma drug concentrations. Some drug actions e.g. anti-thrombin III binding and inhibition of Factor Xa by
More informationOne-Compartment Open Model: Intravenous Bolus Administration:
One-Compartment Open Model: Intravenous Bolus Administration: Introduction The most common and most desirable route of drug administration is orally by mouth using tablets, capsules, or oral solutions.
More informationDrug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila
Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal
More informationResearch Article. Shital S. Ahire 1 *, Shweta Mhambrey 1, Sambharana Nayak 2. Received: 22 July 2016 Accepted: 08 August 2016
International Journal of Research in Medical Sciences Ahire SS et al. Int J Res Med Sci. 2016 Sep;4(9):3838-3844 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20162824
More informationVECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION
Br. J. Anaesth. (1985), 57, 765-769 VECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION J. E. CALDWELL, J. M. BRAIDWOOD AND D. S. SIMPSON Although artificial ventilation can be used to avoid
More informationPREOPERATIVE SEDATION BEFORE REGIONAL ANAESTHESIA: COMPARISON BETWEEN ZOLPIDEM, MIDAZOLAM AND PLACEBO
British Journal of Anaesthesia 1990; 64: 670-674 PREOPERATIVE SEDATION BEFORE REGIONAL ANAESTHESIA: COMPARISON BETWEEN ZOLPIDEM, MIDAZOLAM AND PLACEBO J. PRAPLAN-PAHUD, A. FORSTER, Z. GAMULIN, E. TASSONYI
More informationOriginal Article INTRODUCTION. Abstract
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2016/600 Randomized Clinical Comparison of Epidural Bupivacaine with Fentanyl and Epidural Levobupivacaine with Fentanyl
More informationThe excretion of zopiclone into breast milk
Br. J. clin. Pharmac. (1990), 30, 267-271 The excretion of zopiclone into breast milk I. MATHESON1, H. A. SANDE2 & J. GAILLOT3 'Department of Pharmacotherapeutics, University of Oslo, Oslo, 2Department
More informationPrinciples of Pharmacokinetics
Principles of Pharmacokinetics Ákos Csomós MD, PhD Associate Professor Institute of Anaesthesia and Critical Care, Semmelweis University, Budapest, Hungary Pharmacokinetics: Very basics How the organ affects
More informationPharmacological methods of behaviour management
Pharmacological methods of behaviour management Pharmacological methods CONCIOUS SEDATION?? Sedation is the use of a mild sedative (calming drug) to manage special needs or anxiety while a child receives
More informationRemifentanil. Addressing the challenges of ambulatory orthopedic procedures 1-3
Remifentanil Addressing the challenges of ambulatory orthopedic procedures 1-3 INDICATIONS AND IMPORTANT RISK INFORMATION INDICATIONS ULTIVA (remifentanil HCl) for Injection is indicated for intravenous
More informationCOMPARATIVE ANAESTHETIC PROPERTIES OF VARIOUS LOCAL ANAESTHETIC AGENTS IN EXTRADURAL BLOCK FOR LABOUR
Br.J. Anaesth. (1977), 49, 75 COMPARATIVE ANAESTHETIC PROPERTIES OF VARIOUS LOCAL ANAESTHETIC AGENTS IN EXTRADURAL BLOCK FOR LABOUR D. G. LITTLEWOOD, D. B. SCOTT, J. WILSON AND B. G. COVINO SUMMARY Various
More informationPreliminary studies of the pharmacokinetics and pharmacodynamics
Br. J. clin. Pharmac. (1987), 23, 137-142 Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers WENDY B. TAYLOR & D. N. BATEMAN Wolfson Unit of Clinical
More informationIhmsen et al. (4) g [mean (SD)], were included in the study. Animals were delivered by Charles River Wiga, Sulzfeld, Germany at least 7 days before th
British Journal of Anaesthesia 95 (): 7 71 (25) doi:1.19/bja/aei179 Advance Access publication June 24, 25 Development of acute tolerance to the EEG effect of propofol in rats { H. Ihmsen*, M. Schywalsky,
More informationIgnacio Cortínez Anesthesiology Department School of Medicine, Pontificia Universidad Católica de Chile
Recommended doses of Levobupivacaine for TAP Blocks: Development of a pharmacokinetic model and estimation of the risk of symptoms of local anesthetic systemic toxicity Ignacio Cortínez Anesthesiology
More informationPharmacology of intravenous induction agents
Pharmacology of intravenous induction agents Ákos Csomós MD, PhD Professor, Head of Department Medical Centre, Hungarian Defence Force, Budapest What do we have in the market? Thiopental Metohexital Etomidate
More informationEffect of Vecuronium in different age group
Original Research Article Effect of Vecuronium in different age group Bharti Rajani 1, Hitesh Brahmbhatt 2, Hemlata Chaudhry 2, Hiren Parmar 3* 1 Associate Professor, Department of Anesthesiology, GMERS
More informationGeneral Principles of Pharmacology and Toxicology
General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University
More information1. Immediate 2. Delayed 3. Cumulative
1 Pharmacodynamic Principles and the Time Course of Delayed Drug Effects Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand The time course of drug action combines
More informationPHARMACOKINETICS OF PROPOFOL IN CHILDREN
British Journal of Anaesthesia 1990; 65: 661-667 PHARMACOKINETICS OF PROPOFOL IN CHILDREN R. D. M. JONES, K. CHAN AND L. J. ANDREW SUMMARY The pharmacokinetics of propofol were studied in 12 healthy Chinese
More informationA specific opioid antagonist, such as naloxone immediately and completely reverses all actions of alfentanil.
RAPIFEN DATA SHEET NAME OF THE MEDICINE RAPIFEN alfentanil 0.5 mg/ml injection PRESENTATION RAPIFEN is a sterile, preservative free, isotonic, aqueous solution containing alfentanil hydrochloride equivalent
More informationOptimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS)
Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS) Georgios Dadoudis Anesthesiologist ICU DIRECTOR INTERBALKAN MEDICAL CENTER Optimal performance requires:
More informationSUMMARY OF PRODUCT CHARACTERISTICS. 1 ml solution contains 75 micrograms of sufentanilcitrate, corresponding to 50 micrograms of sufentanil.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Sufentanil Narcomed, 50 microgram / ml, solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution contains 75
More informationPharmacology in the obese : does weight matter?
A A Pharmacology in the obese : does weight matter? Michel MRF Struys, MD, PhD Professor and Chair, Department of Anesthesia University Medical Center Groningen Groningen, The Netherlands Professor of
More informationC OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:
LESSON 2 Basic Pharmacokinetics C OBJECTIVES After completing Lesson 2, you should be able to: 1. Define the concept of apparent volume of distribution and use an appropriate mathematical equation to calculate
More informationPREMEDICATION BEFORE DAY SURGERY
Br.J. Anaesth. (1985), 57, -5 REMEDICATION BEFORE DAY SURGERY A Double-Blind Comparison ofdiazepam and lacebo H. JAKOBSEN, J. B. HERTZ, J. R. JOHANSEN, A. HANSEN AND K. KLLIKER The benzodiazepines are
More informationEvaluation of the gravimetric method of propofol infusion with intermittent ketamine injections for total intravenous anaesthesia (TIVA)
JMBR: A Peer-review Journal of Biomedical Sciences June 2005 Vol. 4 No.1 pp-65-70 Evaluation of the gravimetric method of propofol infusion with intermittent ketamine injections for total intravenous anaesthesia
More informationRauf et al. The evidence for this effect is equivocal. Studies of volunteers and non-cardiac surgery patients have concluded that there is no toleranc
British Journal of Anaesthesia 95 (5): 611 15 (2005) doi:10.1093/bja/aei237 Advance Access publication September 9, 2005 Remifentanil infusion in association with fentanyl propofol anaesthesia in patients
More informationDETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES
British Journal of Anaesthesia 1991; 66: 469-45 DETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES G. H. BEEMER, A. R. BJORKSTEN, P. J. DAWSON, R. J. DAWSON, P.
More informationULTIVA GlaxoSmithKline
ULTIVA GlaxoSmithKline Remifentanil QUALITATIVE AND QUANTITATIVE COMPOSITION Remifentanil for injection is a sterile, endotoxin-free, preservative-free, white to off white, lyophilised powder, to be reconstituted
More informationThe effect of desflurane on rocuronium onset, clinical duration and maintenance requirements
(Acta Anaesth. Belg., 2006, 57, 349-353) The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements R. G. STOUT (*), T. J. GAN (**), P. S. A. GLASS (***), D. G. SILVERMAN
More informationEXTRADURAL MORPHINE: INFLUENCE OF ADRENALINE ADMIXTURE
Br. J. Anaesth. (1986), 58, 598-4304 EXTRADURAL ORPHINE: INFLUENCE OF ADRENALINE ADIXTURE G. NORDBERG, T. ELLSTRAND, L. BORG AND T. HEDNER Spinal opiate analgesia is now accepted widely in clinical practice
More informationAs laparoscopic surgeries are gaining popularity, Original Article. Maharjan SK 1, Shrestha S 2 1. Introduction
, Vol. 1, No. 1, Issue 1, Jul.-Sep., 2012 Original Article Maharjan SK 1, Shrestha S 2 1 Associate Professor, 2 Assistant Professor, Department of Anaesthesiology and Intensive Care Kathmandu Medical College,
More information